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ABSTRACT
Aims/Introduction: Gestational diabetes mellitus (GDM) is defined as ‘carbohydrate intol-
erance of varying degrees of severity with onset or first recognition during pregnancy,’
and is associated with increased fetal and maternal risks. The aims of the present study
were to investigate the prevalence of GDM in Scotland over 32 years (1981–2012), and
using the data from 2012, to assess how GDM related to maternal body mass index,
maternal age, parity, smoking, Scottish Index of Multiple Deprivation, infant gender and
macrosomia status.
Materials and Methods: GDM prevalence along with anthropometric, obstetric and
demographic data were collected on a total of 1,891,097 women with a delivery episode
between 1 January 1981 and 31 December 2012 using data extracted from the Scottish
Morbidity Record 02. Univariate and multivariate logistic regression analysis was under-
taken to investigate their association with GDM.
Results: A ninefold increase in GDM prevalence was observed from 1981 to 2012
(P < 0.001). GDM prevalence in 2012 was 1.9%. Maternal body mass index, age, parity sta-
tus, Scottish index of multiple deprivation and fetal macrosomia were positively associated
with GDM. Reported smoking status at booking was inversely associated with GDM. Multi-
variable analysis showed that fetal macrosomia was not associated with GDM status.
Conclusions: The present study confirmed that the reporting of GDM is low in Scot-
land, and that GDM is associated with maternal body mass index, maternal age, multipar-
ity and social deprivation. GDM was negatively associated with smoking and requires
further investigation. The lack of association between GDM and macrosomia (following
multivariate analysis) might reflect the screening processes undertaken in Scotland.
INTRODUCTION
Gestational diabetes mellitus (GDM) is defined as ‘carbohydrate
intolerance of varying degrees of severity with onset or first
recognition during pregnancy’1,2. Although traditionally deemed
not as dangerous for the developing fetus as developing dia-
betes prepregnancy, we now know that GDM has serious long-
term consequences for both the baby and the mother3,4. The
altered intrauterine milieu of hyperglycemia and associated fetal
hyperinsulinemia promotes fetal growth and adiposity, which
can be referred to as ‘fetal overnutrition’. Neonatal hyperbiliru-
binemia, hypoglycemia, hypocalcemia, erythremia, poor feeding,
respiratory distress syndrome and pre-eclampsia are also recog-
nized complications of GDM5,6. Infants born to mothers who
have glucose intolerance have 20% higher body fat than infants
born to mothers with normal glucose tolerance6. The cesarean
section delivery rate is increased in patients with GDM6. This
is in part to avoid birth trauma, particularly to avoid the risks
of shoulder dystocia and newborn asphyxia, both associated
with large-for-gestational-age newborns. Epidemiological
research confirms that women who have gestational diabetes
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have a significant increased risk of type 2 diabetes later in
life7,8, and also suggests that excessive fetal growth is associated
with glucose intolerance and obesity in the offspring9,10.
There are few areas in diabetes that are associated with as
much debate and discussion as the diagnosis of GDM11. Evi-
dence suggests early detection and management of gestational
diabetes improves outcomes for both mother and child12. In
2001, the Scottish Intercollegiate Network Guidelines (SIGN
55) provided guidelines for the screening of GDM in Scotland.
In 2010, based on the International Association of Diabetes
and Pregnancy Study Groups Consensus Panel13, SIGN 116
provided further guidelines for GDM with lower plasma glu-
cose levels14. The aim of the present study was to investigate
the reported prevalence of GDM in Scotland over 31 years
(1981–2012), and to assess how the risk factors of maternal
body mass index (BMI), maternal age, parity, patients’ socioe-
conomic status, smoking status at booking, and the change in
the diagnostic criteria related to the reported prevalence of
GDM and macrosomia.
METHODS
Data source
The linked Scottish Morbidity Record (SMR02) was established
in 1975 and collects data from maternity hospitals that are sub-
mitted to the Information Services Division (ISD) of National
Health Service (NHS) National Services Scotland. Women
delivering at home or in non-NHS hospitals were not included
in this data collection. Data were extracted in July 2012 and
July 2014 from SMR02, for a total of 1,891,097 women with a
delivery episode, discharged from hospital between 1 January
1981 and 31 December 2012. The data extracted were aggre-
gated into the following 5-year periods, 1981–1985; 1986–1990;
1991–1995; 1996–2000; 2001–2005; 2006–2010, plus the years
2011 and 2012.
Variables
The BMI of pregnant women was defined as <25 kg/m2 (un-
derweight and normal), 25–30 kg/m2 (overweight), 30–40 kg/
m2 (obese) or BMI data not known. Data relating to weight
and height were optionally recorded before 2003, and have only
been made mandatory since April 2011, at antenatal ‘booking’
clinics, which take place first at week 12 of pregnancy.
Obstetric variables characterized GDM status, parity status,
smoking status during pregnancy, number of births during
the delivery episode, fetal macrosomia status of the offspring
and offspring gender. Mothers were defined as having GDM
if coded as ‘gestational diabetes’ or if any of the diagnosis
were coded as O244 (ICD10) or 6488 (ICD9) in the SMR02
dataset, otherwise they were classified as not having GDM.
Parity status of the mothers was defined as multiparous,
primiparous or not known. Maternal smoking status defined
as yes, no or not known, was derived from self-reported
information obtained from mothers at their antenatal booking
visit only from 1993 onwards. The number of births during
this delivery episode was defined as singleton or multiple.
Fetal macrosomia status of the offspring was defined as babies
birthweight <4,000 g (no fetal macrosomia) or ≥4,000 g (fetal
macrosomia). Offspring gender was defined as female, male
and other/not known.
Demographic variables were characterized by maternal age
and Scottish Index of Multiple Deprivation (SIMD) 2012. Mater-
nal age was grouped as <24 years, 25–29 years, 30–34 years, 35–
39 years, ≥40 years or not known. The 2012 SIMD quintiles,
defined as 1 (most deprived), 2, 3, 4 or 5 (least deprived) and not
known, provided an area-based measure of deprivation of the
mother–child dyad. SIMD replaced the Carstairs index in 2004,
and ranks the 6,505 geographic data zones in Scotland on the
basis of the level of deprivation, with 31 indicators across seven
domains, including current income, housing and health15.
The number of delivery episodes and percentages observed
within the anthropometric, obstetric, and demographic variables
for the intervals 1981–2010, 2006–2010, 2011 and 2012 are
summarized in Table 1.
Data analysis
GDM prevalence estimates were determined as a proportion of
the total number of NHS delivery episodes for each of the fol-
lowing 5-year periods, 1981–1985, 1986–1990, 1991–1995,
1996–2000, 2001–2005, 2006–2010 plus 2011 and 2012. The
results were reported as estimated GDM prevalence – standard
error (%). Standard error (%) was calculated to illustrate the
uncertainty of the GDM prevalence estimates using the follow-
ing formula:
 ffiffi
x
p
n

 100, where ‘x’ is the number of GDM
cases and ‘n’ is the total number of NHS delivery episodes
diagnosed with GDM plus total number of NHS delivery epi-
sodes not diagnosed with GDM.
The fold-change in estimated GDM prevalence was calcu-
lated before and after the introduction of the SIGN 116 guid-
ance to gain insight into how changes in screening and
diagnostic criteria affected the estimated GDM prevalence
levels. Likewise an online survey carried out by Stirrat et al.
investigating the screening and management of GDM in 15
Scottish maternity units have been published elsewhere16.
Statistical analysis
All statistical analysis was carried out using IBM SPSS 19
(IBM, Armonk, NY, USA). The v2-test was carried out to (i)
assess trends of estimated GDM prevalence over the time-per-
iod of 1981–2012; all the data extracted from the linked
SMR02 was included in this analysis; and (ii) assess trends/as-
sociations between GDM status and risk factor variables using
the 2006–2010 subgroup from the NHS delivery episode dataset
(reference dataset: IR2012-01211) and 2012 NHS delivery epi-
sodes dataset (reference dataset: IR2015-00505_macrosomia;
Table 2. Using the 2012 NHS delivery episodes dataset, univari-
ate logistic regression models were created to examine the mag-
nitude of association between the dependent variable, GDM
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status, and the following independent variables (i) maternal
BMI status; (ii) maternal age groups; (iii) parity status; (iv)
smoking status; (v) SIMD quintile status; or (vi) fetal macroso-
mia status. The results were reported as odds ratio (OR) with
their respective 95% confidence interval (CI). Finally, a multi-
variate logistic regression model was created to identify factors
that have a significant independent influence on GDM status
and their magnitude of effect. The results were reported as
Table 1 | Summary of anthropometric, obstetric and demographic variables for all National Health Service delivery episodes in Scotland from
January 1981 to December 2010
Characteristics 1981–2010 2006–2010 2011 2012
n % n % n % n %
BMI (kg/m2) 1,776,845 100.0 281,983 100.0 57,018 100.0 57,234 100.0
<25 124,041 7.0 94,608 33.6 25,434 44.6 24,995 43.7
25–30 67,447 3.8 51,586 18.3 13,669 24.0 23,690 41.4
30–40 48,511 2.7 37,282 13.2 10,371 18.2 13,508 23.6
Not known 1,536,846 86.5 98,507 34.9 7,544 13.2 8,444 14.8
GDM 1,776,845 100.0 281.983 100.0 57.018 100.0 57,234 100.0
Yes 8,323 0.5 2,156 0.8 723 1.3 1,098 1.9
No 1,768,522 99.5 279,827 99.2 56,295 98.7 56,136 98.1
Parity status 1,776,845 100.0 281,983 100.0 57,018 100.0 57,234 100.0
Multiparous 971,996 54.7 145,553 51.6 29,235 51.3 31,711 55.4
Primiparous 799,769 45.0 135,268 48.0 26,923 47.2 25,415 44.4
Not known 5,080 0.3 1,162 0.4 860 1.5 108 0.2
Smoking status 1,776,845 100.0 281,983 100.0 57,018 100.0 57,234 100.0
Yes 232,360 37.0 52,133 18.5 10,292 18.1 10,226 17.9
No 657,668 13.1 197,528 70.0 43,025 75.5 43,824 76.6
Not known 886,817 49.9 32,322 11.5 3,701 6.5 3,184 5.6
Maternal age 1,776,845 100.0 281,983 100.0 57,018 100.0 57,234 100.0
≤24 years 567,929 32.0 73,786 26.2 13,776 24.2 13,341 23.3
25–29 years 561377 31.6 75,101 26.6 15,518 27.2 15,819 27.6
30–34 years 435491 24.5 76,728 27.2 16,384 28.7 16,958 29.6
≥35 years 212037 11.9 56,368 20.0 11,340 19.9 11,114 19.4
Not known 11 0.001 0 0 0 0.0 2 0.003
SIMD quintiles 1,776,845 100.0 281,983 100.0 57,018 100.0 57,234 100.0
1 484,447 27.3 72,605 25.7 15,161 26.6 15,100 26.4
2 352,668 19.8 58,677 20.8 12,105 21.2 12,197 21.3
3 313,108 17.6 52,733 18.7 10,638 18.7 10,930 19.1
4 297,438 16.7 50,788 18.0 9,916 17.4 9,728 17.0
5 290,896 16.4 45,993 16.3 8,898 15.6 8,952 15.6
Not known 38,288 2.2 1,187 0.4 300 0.5 327 0.6
Fetal macrosomia – – – – – – 57,234 100.0
No – – – – – – 49,380 86.3
Yes – – – – – – 7,854 13.7
Births this pregnancy – – – – – – 57234 100.0
Multiple – – – – – – 1,691 3.0
Singleton – – – – – – 55,543 97.0
Offspring gender 57,234 100.0
Female – – – – – – 27,868 48.7
Male – – – – – – 29,360 51.3
Other/not Known – – – – – – 6 0.01
Summary of anthropometric (body mass index [BMI]), obstetric (gestational diabetes mellitus [GDM] status, parity status, smoking status during preg-
nancy, number of births during the delivery episode, fetal macrosomia status, infant gender) and demographic (maternal age, Scottish Index of Mul-
tiple Deprivation [SIMD]) variables for all national Health Service delivery episodes in Scotland from 1 January 1981 to 31 December 2010 (dataset
reference: IR2012-01211; n = 1,776,845), 1 January 2006 to 31 December 2010 (dataset reference: subgroup from IR2012-01211, n = 281,983), 1 Jan-
uary 2011 to 31st December 2011 (Dataset reference: IR2013-02036; n = 57,018) and 1st January 2012 to 31 December 2012 (dataset reference:
IR2015-00505_macrosomia; n = 57,234). The datasets also include cases labeled as ‘not known’.
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adjusted odds ratio (AOR) with their respective 95% CI. When
creating the logistic regression statistical models, cases with one
or more data points classified as ‘not known’ were excluded
(n = 9,944). The working file contained 47,290 cases for the
statistical analysis results presented in Table 2.
RESULTS
During the survey period 1981–2010, estimated GDM preva-
lence, calculated as a proportion of total number of NHS deliv-
ery episodes in each 6-year period, increased fourfold from
0.21 – 0.01% (n = 690/325,953) in 1981–1985, to 0.76 – 0.02%
(n = 2,156/281,983) in 2006–2010 (v2[1] = 1243.0; P < 0.001).
After the introduction of the 2010 SIGN 116, a further 2.5-fold
increase in estimated GDM prevalence was observed between
time-points 2006–2010 and 2012. Overall, a ninefold increase
in GDM prevalence was observed from 1981 to 2012
(v2[1] = 2,987.8; P < 0.001). GDM prevalence in 2012 was
1.92 – 0.06% (n = 1,097/57,231; Figure 1).
Association between maternal characteristics and GDM
prevalence
Within the 2006–2010 NHS delivery episode sample, GDM
prevalence showed a positive monotonic association with
maternal BMI (v2[1] = 1,215.8, P < 0.001), maternal age
Table 2 | Univariate and multivariate associations with gestational diabetes mellitus status and risk factors
Total No. GDM
(referent)
GDM yes OR 95% CI AOR† 95% CI
n % n % n % v2-test (P)2 AOR‡ 95% CI
BMI (kg/m2) 47,290 100 46,317 100 973 100 v2(1) = 758.8§
<25 24,221 51.2 24,049 51.9 172 17.7 P < 0.001 1.0 Reference 1.0 Reference
25–30 13,071 27.6 12,826 27.7 245 25.2 2.7 2.2–3.3 2.5 2.1–3.1
30–40 9,998 21.1 9,442 20.4 556 57.1 8.2 6.9–9.8 7.7 6.5–9.2
Maternal age 47,290 100 46,317 100 973 100 v2(1) = 170.8§
≤24 years 10,920 23.1 10,806 23.3 114 11.7 P < 0.001 1.0 Reference
25–29 years 13,090 27.7 12,880 27.8 210 21.6 1.5 1.2–1.9
30–34 years 14,030 29.7 13,714 29.6 316 32.5 2.2 1.8–2.7
≥35 years 9,250 19.6 8,917 19.3 333 34.2 3.5 2.9–4.4
Parity status 47,290 100 46,317 100 973 100 v2(1) = 170.8¶
Primiparous 20,698 43.8 20,335 43.9 363 37.3 P < 0.001 1.0 Reference
Multiparous 26,592 56.2 25,982 56.1 610 62.7 1.3 1.2–1.5
Smoking status 47,290 100 46,317 100 973 100 v2(1) = 12.4¶
No 38,369 81.1 37,537 81.0 832 85.5 P < 0.001 1.0 Reference
Yes 8,921 18.9 8,780 19.0 141 14.5 0.7 0.6–0.9
SIMD quintile 47,290 100 46,317 100 973 100 v2(1) = 6.5§
1 - Most deprived 11,305 23.9 11,052 23.9 253 26.0 P = 0.011 1.3 1.1–1.7
2 10,264 21.7 10,043 21.7 221 22.7 1.3 1.0–1.6
3 9,501 20.1 9,305 20.1 196 20.1 1.2 1.0–1.5
4 8,484 17.9 8,311 17.9 173 17.8 1.2 1.0–1.5
5 - Least deprived 7,736 16.4 7,606 16.4 130 13.4 1.0 Reference
Fetal macrosomia 47,290 100 46,317 100 973 100 v2(1) = 8.1¶
No 40,742 86.2 39,934 86.2 808 83.0 P = 0.005 1.0 Reference 1.0 Reference
Yes 6,548 13.8 6,383 13.8 165 17.0 1.3 1.1–1.5 1.0 0.8–1.2
Births 47,290 100 46,317 100 973 100 v2(1) = 1.4¶
Single 45,936 97.1 44,997 97.2 939 96.5 P = 0.233
Multiple 1,354 2.9 1,320 2.8 34 3.5
Gender 47,290 100 46,317 100 973 100 v2(1) = 0.8¶
Male 24,297 51.4 23,811 51.4 486 49.9 P = 0.367
Female 22,993 48.6 22,506 48.6 487 50.1
Univariate and multivariate associations with gestational diabetes mellitus (GDM) status and risk factors (maternal body mass index [BMI]/maternal
age/maternal parity status/maternal smoking status during pregnancy/maternal Social Index of Multiple Deprivation (SIMD)/fetal macrosomia/num-
ber of births during the delivery episode/infant gender). †Adjusted for maternal BMI, maternal age, parity status, smoking status and maternal SIMD
status. ‡Adjusted for maternal BMI, maternal age, parity status, smoking status, maternal SIMD status and fetal macrosomia. National Health Service
delivery episodes in Scotland from 1 January 2012 to 31 December 2012 (dataset reference: IR2015-00505_macrosomia; n = 57,234) with n = 9,944,
data-points classified as ‘not known’ removed from the sample. §The v2-test for trend. ¶Pearson’s v2-test. AOR, adjusted odds ratio; CI, confidence
interval; OR, odds ratio.
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(v2[1] = 328.4, P < 0.001) and maternal parity status
(v2[1] = 66.5, P < 0.001). GDM subgroup analysis of BMI dis-
tribution within the 2012 GDM sample (n = 973) showed that
17.7% (172/973) had BMI <25 kg/m2, 25.1% (245/973) had
BMI 25–30 kg/m2 and 57.1% (556/973) had BMI 30–40 kg/m2.
Maternal smoking status was inversely associated with GDM
(v2[1] = 12.4, P < 0.001; Table 2). In the 2011 and 2012 NHS
delivery episode samples, similar GDM prevalence trends were
observed across the maternal BMI, maternal age, maternal par-
ity status and maternal smoking status stratified groups. In the
2012 sample, there was a clear monotonic decrease in GDM
prevalence as maternal deprivation decreased from the most
deprived SIMD quintile 1, to the least deprived SIMD quintile
5, (v2[1] = 6.5, P = 0.011; Table 2). There was no association
between single or multiple births, or the sex of the baby and
GDM.
Association between GDM and fetal macrosomia
The univariate model showed that the presence of maternal
GDM was a significant positive predictor of fetal macrosomia
(OR 1.3, 95% CI 1.1–1.5). However, after adjusting for maternal
BMI, SIMD, maternal age, parity and maternal smoking status,
fetal macrosomia was not associated with maternal GDM status
(AOR 1.0, 95% CI 0.8–1.2).
Association between fetal macrosomia and SIMD after
adjustment for maternal BMI
Both maternal obesity and the presence of GDM were observed
to be positively associated with the presence of fetal macroso-
mia. Fetal macrosomia was not influenced by either maternal
BMI or maternal age when SIMD status was taken into
account. Fetal macrosomia was inversely associated with SIMD
quintile 1 (AOR 0.7, 95% CI 0.7–0.8), SIMD quintile 2 (AOR
0.8, 95% CI 0.8–0.9), SIMD quintile 3 (AOR 0.9, 95% CI 0.8–
1.0) and positively associated with SIMD quintile 4 (AOR 1.1,
95% CI 1.0–1.2), when compared with the least deprived SIMD
quintile 5 after adjustment for maternal BMI. The addition of
maternal age to the model did not change the observed AORs
reported above.
Association between fetal macrosomia and maternal age
The prevalence of fetal macrosomia in the sample of women
who were obese (BMI 30–40 kg/m2) was 15.2% (318/2,094),
19.4% (567/2,928), 21.1% (600/2,847), and 19.0% (405/2,129) in
those aged ≤24 years, 25–29 years, 30–34 years and ≥35 years,
respectively. In those with a BMI <25 kg/m2 and aged
≤24 years, 25–29 years, 30–34 years or ≥35 years, the preva-
lence of fetal macrosomia was 8.5% (522/6118), 10.9% (725/
6629), 11.6% (836/7179) and 12.5% (536/4295), respectively.
After adjustment for maternal BMI, it was observed that moth-
ers aged ≤24 years were less likely to give birth to an offspring
with fetal macrosomia (AOR 0.7, 95% CI 0.7–0.8) compared
with those aged ≥35 years. Obese mothers (BMI 30–40 kg/m2)
were 1.9-fold (95% CI 1.8–2.0) more likely to have a baby with
fetal macrosomia, after adjusting the model for maternal age.
Obese mothers were 8.0-fold (95% CI 6.7–9.5) more likely to
be diagnosed with GDM, so it was unexpected that fetal
macrosomia was not associated with GDM.
Association between fetal macrosomia and smoking during
pregnancy
Further analysis showed that smoking at booking was found to
be inversely associated with fetal macrosomia (AOR 0.4, 95%
CI 0.4–0.4) before and after adjusting the model for the con-
founding factors describing maternal characteristics. There was
a minimal association observed between fetal macrosomia and
maternal SIMD quintile 1 (AOR 0.9, 95% CI 0.8–1.0), SIMD
quintile 2 (AOR 1.0, 95% CI 0.9–1.1), SIMD quintile 3 (AOR
1.0, 95% CI 0.9–1.1) and SIMD quintile 4 (AOR 1.1, 95% CI
1.0–1.2) compared with SIMD quintile 5, after adjustment for
just smoking status. The prevalence of smoking at booking was
32.1% (3,626/11,305), 23.4% (2,402/10,264), 15.9% (1,511/
9,501), 10.9% (924/8,484), and 5.9% (458/7,736) in SIMD quin-
tile 1, 2, 3, 4 and 5, respectively.
DISCUSSION
The major strength of our observations is that they were taken
from a national database, containing a large number of patient
data, with a proven track record of accuracy and quality of
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Figure 1 | Reported prevalence of gestational diabetes mellitus (GDM)
across the 5-year periods from 1 January 1981 to 31 December 2010
(dataset reference: IR2012-01211; n = 1,776,845), from 1 January 2011 to
31 December 2011 (dataset reference: IR2013-02036; n = 57,018) and
from 1 January 2012 to 31 December 2012 (dataset reference: IR2015-
00505_macrosomia; n = 57,234) based on data submitted to the
Information Services Division of NHS National Services Scotland from
Scottish Maternity Hospitals. The vertical bars represent standard errors
for each point estimate of GDM prevalence. The arrows illustrate the
introduction of the Scottish Intercollegiate Network Guidelines SIGN 55
and 116 ‘Management of Diabetes’ guidelines. The v2-test for trend
(1) = 2,987.8; P < 0.001.
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data17,18. The method of record linkage used in Scotland is esti-
mated to result in mismatched records in less than 2% of
cases16. In the present study we showed a fourfold increase in
reported GDM over 31 years (1981–2010), with a further sig-
nificant rise after the introduction of new guidelines in 2010.
The prevalence of GDM in 2012 in the present study was
1.9%, which is very similar to the recently published Scottish
data from Stirrat et al.19 The present study confirmed the asso-
ciation of GDM with maternal BMI, maternal age, multiparity
and social deprivation20,21. However, we found that GDM was
negatively associated with smoking. In addition, after adjusting
for maternal BMI, SIMD, maternal age, parity and maternal
smoking status, we showed that fetal macrosomia was not asso-
ciated with maternal GDM status. There was no association
between single, multiple births or the sex of the baby and
GDM.
A few studies have investigated the association between
smoking and GDM, and have shown both positive and nega-
tive correlations22,23. For example, the Nurse Cohort study
involving USA women showed a significant association, with a
relative risk for GDM of 1.43 in pregravid current smokers24.
Contrary to the popular belief that smokers have a lower BMI
compared with non-smokers25, the present study showed that
within the GDM sample 58.0% of smokers were obese, whereas
just 21.2% of smokers had BMI <25 kg/m2. There are, how-
ever, some limitations to the way data relating to smoking was
collected in the present study. We do not know if patients con-
tinued to smoke during their pregnancy or if smoking had an
effect on maternal weight during the pregnancy. Although
smoking seems to be associated with reduced infant weight, it
masks potential short-term and long-term adverse health condi-
tions in both the mother and infant. Further investigation is
clearly required to understand the association between smoking
and GDM.
We also found that after multivariate analysis, fetal macroso-
mia was not associated with GDM. This might be explained by
the fact that over 80% of the sample had a BMI <30 kg/m2 at
booking. It is possible that maternal obesity and the associated
insulin resistance is a bigger influence on macrosomia than
GDM. Another explanation might lie in the screening process.
Estimates of up to 4–6% of pregnancies having GDM are
reported in the majority of the studies across Europe and
North America.11,26 We are aware that in Scotland there are
significant inconsistencies between health boards related to risk
factor screening, and that we are missing a significant number
of patients with GDM19. The lack of association between
macrosomia and GDM might reflect that we are screening
more overweight/obese, socially deprived pregnant patients and
missing the less heavy, less deprived patients. Systematic review
and meta-analysis have found that screening using risk factors
alone produces low sensitivities (50–69%) and low specificities
(58–69%)27. Maternity units that are using screening risk factors
alone, or only screening at a higher BMI might be significantly
under diagnosing GDM.
This then begs the questions as to whom, how and when
should screening take place? We know from large and well-
powered randomized controlled trials plus observational studies
that appropriate management reduces the risks of GDM28–30.
These studies have purportedly clarified some of the main
issues relating to GDM and have informed national clinical
guidelines. However, there are still no internationally agreed
diagnostic criteria11,31. Agreed criteria are required to train clin-
icians about GDM screening, to improve clinical practice and
to aid further research. With increased provision of information
and appropriate screening, we anticipate that the reported
prevalence of GDM will increase significantly. In an already
stretched NHS, the diagnosis of more GDM patients will put
more pressure on available resources. Obesity, with its associ-
ated problems, appears to be the main driver in the develop-
ment GDM. Concerted efforts by national government,
together with community services, schools, sports clubs and
local councils along with the NHS are required to raise aware-
ness and campaign for optimal lifestyle management during
childhood, adolescence, particularly pregnancy and adult life to
curb the continuing obesity epidemic.
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